Sign inJoin waitlistJoin the waitlist

DM

Deborah McMahon

Medical Director of PACT and Consultant for HIV/AIDS Care in Africa · UPMC Medical Education

Credentials: · · · ·

History

PACT and Consultant for HIV/AIDS Care in Africa · UPMC Medical Education
Present

Infectious Disease
1984–1986
Internal Medicine
1981–1984
Temple University School of Medicine
1977–1981

Research

Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy
New England Journal of Medicine · 1997 · 1,591 citations
Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing
PLoS Pathogens · 2014 · 245 citations
Simultaneous vs sequential initiation of therapy with indinavir, zidovudine, and lamivudine for HIV-1 infection: 100-week follow-up
JAMA · 1998 · 204 citations

JM
John Mellors
48 papers
Rajesh Gandhi
29 papers
Joseph Eron
28 papers
AM
Alison Morris
19 papers
Sharon Riddler
10 papers
Ann Collier
8 papers
Laurence Huang
8 papers
MG
Matthew Gingo
8 papers · 1 as a fellow
ED
Eric Daar
7 papers
Meghan Fitzpatrick
7 papers
CG
Catherine Godfrey
6 papers
Diane Havlir
5 papers

Grants

General Clinical Research Center
National Center for Research Resources · M01
Project lead · $2.7K · Children's Hosp Pittsburgh/Upmc Hlth Sys
2003–2004

Clinical trials

Pilot Study of Adding Raltegravir (MK-0518) to Antiretroviral Therapy in Patients With Low Level Viremia
Principal investigator · Completed
University of Pittsburgh
2007–2009
Evaluating the Safety and Efficacy of Romidepsin in Combination With Antiretroviral Therapy in HIV-Infected Adults With Suppressed Viral Load
Study chair · Completed · Phase 1, Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2014–2018
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)
2006–2011
Comparing Standard-Dose Versus Adjusted-Dose Lopinavir/Ritonavir Therapy in HIV-Infected Persons With Drug Resistance
Study chair · Completed · Phase 2
National Institute of Allergy and Infectious Diseases (NIAID)